The general mood among these heavyweight investors is divided, with 41% leaning bullish and 41% bearish. Among these notable options, 3 are puts, totaling $371,983, and 9 are calls, amounting to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

For further information please contact: Mr. René C. Goehrum President and CEO BioSyent Inc. E-Mail: ... Phone: 905-206-0013 Web: ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and ...

A viral video features Saudi equestrian Shahd Al Shammari shopping at a pharmacy while riding a horse. Known for her ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexicon Pharmaceuticals (LXRX – Research Report) and Allakos ...

By earning this URAC Specialty Pharmacy Reaccreditation, Soleo Health was acknowledged for its dedication to patient satisfaction and ability to ensure positive clinical outcomes while demonstrating ...

How much is Manulife Fin stock worth? Invest with precise valuations. Get Report.